Report Detail

Pharma & Healthcare Global Female Sexual Dysfunction Treatment Market Size, Status and Forecast 2019-2025

  • RnM3689021
  • |
  • 22 August, 2019
  • |
  • Global
  • |
  • 97 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Sexual dysfunction is difficulty experienced by an individual or a couple during any stage of a normal sexual activity, including physical pleasure, desire, preference, arousal or orgasm.
The increasing prevalence of chronic diseases is one of the key factors that will drive the growth of the market during the forecast period. Women suffering from chronic health conditions such as diabetes may also be diagnosed with sexual dysfunction. Clinical indications, including hypertension, obesity, metabolic syndrome, and atherogenic dyslipidemia, of chronic conditions such as diabetes, are the risk factors for sexual dysfunctions in women. The rising prevalence of chronic health conditions in women will increase the incidence of female sexual dysfunctions. This will provide considerable growth opportunities to market participants.

Mental health conditions such as depression are being recognized as critical health issues mostly among women. As a result, many pharmaceutical companies are releasing drugs and therapies to treat these conditions leading to an increase in the consumption of antidepressants, antipsychotics, and antiepileptics. Moreover, there is also an increase in the consumption of contraceptives. These drugs cause sexual dysfunctions in women.
In 2018, the global Female Sexual Dysfunction Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Female Sexual Dysfunction Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Female Sexual Dysfunction Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
AMAG Pharmaceuticals Inc.
Duchesnay Inc.
Emotional Brain BV
Novo Nordisk AS
Sprout Pharmaceuticals Inc.
...

Market segment by Type, the product can be split into
Non-hormonal Therapy
Hormonal Therapy

Market segment by Application, split into
Sexual Desire Disorders
Sexual Arousal Disorders
Orgasm Disorders
Sexual Pain Disorders
Post-orgasmic Diseases
Pelvic Floor Dysfunction
Other

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Female Sexual Dysfunction Treatment status, future forecast, growth opportunity, key market and key players.
To present the Female Sexual Dysfunction Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Female Sexual Dysfunction Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Female Sexual Dysfunction Treatment Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Non-hormonal Therapy
      • 1.4.3 Hormonal Therapy
    • 1.5 Market by Application
      • 1.5.1 Global Female Sexual Dysfunction Treatment Market Share by Application (2019-2025)
      • 1.5.2 Sexual Desire Disorders
      • 1.5.3 Sexual Arousal Disorders
      • 1.5.4 Orgasm Disorders
      • 1.5.5 Sexual Pain Disorders
      • 1.5.6 Post-orgasmic Diseases
      • 1.5.7 Pelvic Floor Dysfunction
      • 1.5.8 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Female Sexual Dysfunction Treatment Market Size
    • 2.2 Female Sexual Dysfunction Treatment Growth Trends by Regions
      • 2.2.1 Female Sexual Dysfunction Treatment Market Size by Regions (2019-2025)
      • 2.2.2 Female Sexual Dysfunction Treatment Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Female Sexual Dysfunction Treatment Market Size by by Players
      • 3.1.1 Global Female Sexual Dysfunction Treatment Revenue by by Players (2014-2019)
      • 3.1.2 Global Female Sexual Dysfunction Treatment Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Female Sexual Dysfunction Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.2 Female Sexual Dysfunction Treatment Key Players Head office and Area Served
    • 3.3 Key Players Female Sexual Dysfunction Treatment Product/Solution/Service
    • 3.4 Date of Enter into Female Sexual Dysfunction Treatment Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Female Sexual Dysfunction Treatment Market Size by Type (2014-2019)
    • 4.2 Global Female Sexual Dysfunction Treatment Market Size by Application (2014-2019)

    5 North America

    • 5.1 North America Female Sexual Dysfunction Treatment Market Size (2014-2019)
    • 5.2 Female Sexual Dysfunction Treatment Key Players in North America
    • 5.3 North America Female Sexual Dysfunction Treatment Market Size by Type
    • 5.4 North America Female Sexual Dysfunction Treatment Market Size by Application

    6 Europe

    • 6.1 Europe Female Sexual Dysfunction Treatment Market Size (2014-2019)
    • 6.2 Female Sexual Dysfunction Treatment Key Players in Europe
    • 6.3 Europe Female Sexual Dysfunction Treatment Market Size by Type
    • 6.4 Europe Female Sexual Dysfunction Treatment Market Size by Application

    7 China

    • 7.1 China Female Sexual Dysfunction Treatment Market Size (2014-2019)
    • 7.2 Female Sexual Dysfunction Treatment Key Players in China
    • 7.3 China Female Sexual Dysfunction Treatment Market Size by Type
    • 7.4 China Female Sexual Dysfunction Treatment Market Size by Application

    8 Japan

    • 8.1 Japan Female Sexual Dysfunction Treatment Market Size (2014-2019)
    • 8.2 Female Sexual Dysfunction Treatment Key Players in Japan
    • 8.3 Japan Female Sexual Dysfunction Treatment Market Size by Type
    • 8.4 Japan Female Sexual Dysfunction Treatment Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Female Sexual Dysfunction Treatment Market Size (2014-2019)
    • 9.2 Female Sexual Dysfunction Treatment Key Players in Southeast Asia
    • 9.3 Southeast Asia Female Sexual Dysfunction Treatment Market Size by Type
    • 9.4 Southeast Asia Female Sexual Dysfunction Treatment Market Size by Application

    10 India

    • 10.1 India Female Sexual Dysfunction Treatment Market Size (2014-2019)
    • 10.2 Female Sexual Dysfunction Treatment Key Players in India
    • 10.3 India Female Sexual Dysfunction Treatment Market Size by Type
    • 10.4 India Female Sexual Dysfunction Treatment Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Female Sexual Dysfunction Treatment Market Size (2014-2019)
    • 11.2 Female Sexual Dysfunction Treatment Key Players in Central & South America
    • 11.3 Central & South America Female Sexual Dysfunction Treatment Market Size by Type
    • 11.4 Central & South America Female Sexual Dysfunction Treatment Market Size by Application

    12 International Players Profiles

    • 12.1 AMAG Pharmaceuticals Inc.
      • 12.1.1 AMAG Pharmaceuticals Inc. Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Female Sexual Dysfunction Treatment Introduction
      • 12.1.4 AMAG Pharmaceuticals Inc. Revenue in Female Sexual Dysfunction Treatment Business (2014-2019))
      • 12.1.5 AMAG Pharmaceuticals Inc. Recent Development
    • 12.2 Duchesnay Inc.
      • 12.2.1 Duchesnay Inc. Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Female Sexual Dysfunction Treatment Introduction
      • 12.2.4 Duchesnay Inc. Revenue in Female Sexual Dysfunction Treatment Business (2014-2019)
      • 12.2.5 Duchesnay Inc. Recent Development
    • 12.3 Emotional Brain BV
      • 12.3.1 Emotional Brain BV Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Female Sexual Dysfunction Treatment Introduction
      • 12.3.4 Emotional Brain BV Revenue in Female Sexual Dysfunction Treatment Business (2014-2019)
      • 12.3.5 Emotional Brain BV Recent Development
    • 12.4 Novo Nordisk AS
      • 12.4.1 Novo Nordisk AS Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Female Sexual Dysfunction Treatment Introduction
      • 12.4.4 Novo Nordisk AS Revenue in Female Sexual Dysfunction Treatment Business (2014-2019)
      • 12.4.5 Novo Nordisk AS Recent Development
    • 12.5 Sprout Pharmaceuticals Inc.
      • 12.5.1 Sprout Pharmaceuticals Inc. Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Female Sexual Dysfunction Treatment Introduction
      • 12.5.4 Sprout Pharmaceuticals Inc. Revenue in Female Sexual Dysfunction Treatment Business (2014-2019)
      • 12.5.5 Sprout Pharmaceuticals Inc. Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Product (2019-2025)
    • 13.2 Market Size Forecast by Application (2019-2025)
    • 13.3 Market Size Forecast by Regions
    • 13.4 North America
    • 13.5 Europe
    • 13.6 China
    • 13.7 Japan
    • 13.8 Southeast Asia
    • 13.9 India
    • 13.10 Central & South America

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 15.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Summary:
      Get latest Market Research Reports on Female Sexual Dysfunction Treatment. Industry analysis & Market Report on Female Sexual Dysfunction Treatment is a syndicated market report, published as Global Female Sexual Dysfunction Treatment Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Female Sexual Dysfunction Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,108.30
      4,662.45
      6,216.60
      3,623.10
      5,434.65
      7,246.20
      596,427.00
      894,640.50
      1,192,854.00
      325,338.00
      488,007.00
      650,676.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report